UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Experimental and clinical cardiology, ISSN 1205-6626, 12/2010, Volume 15, Issue 4, pp. e96 - e99
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 12/2014, Volume 64, Issue 21, pp. 2281 - 2293
comorbidities | ejection fraction | heart failure | ejection fraction | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Kidney Diseases - physiopathology | Arthritis - physiopathology | Sleep Apnea Syndromes - physiopathology | Age Factors | Comorbidity | Humans | Heart Failure - physiopathology | Stroke Volume - physiology | Obesity - physiopathology | Pulmonary Disease, Chronic Obstructive - physiopathology | Anemia - physiopathology | Mobility Limitation | Diabetes Mellitus - physiopathology | Sex Factors | Continental Population Groups | Chronic obstructive pulmonary disease | Heart attacks | Drug therapy | Cardiology | Mortality
Journal Article
European heart journal. Cardiovascular pharmacotherapy, ISSN 2055-6837, 01/2015, Volume 1, Issue 1, pp. 13 - 14
Journal Article
European heart journal, ISSN 0195-668X, 08/2017, Volume 38, Issue 32, pp. 2473 - 2477b
C-REACTIVE PROTEIN | DENSITY-LIPOPROTEIN CHOLESTEROL | PRIMARY NONADHERENCE | DRUG-THERAPY | MYOCARDIAL-INFARCTION | PATIENT EDUCATION | CARDIOVASCULAR-DISEASE | LOWERING MEDICATIONS | CLINICAL-PRACTICE | SECONDARY PREVENTION | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Medication Adherence | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cardiovascular Diseases - mortality | Cardiology - organization & administration | Practice Guidelines as Topic | Index Medicus
Journal Article
European heart journal, ISSN 0195-668X, 01/2017, Volume 38, Issue 3, pp. 143 - 153
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Myocardial Infarction - diagnosis | Troponin - metabolism | Plaque, Atherosclerotic - complications | Diagnosis, Differential | Age Factors | Vascular Diseases - complications | Myocarditis - complications | Humans | Magnetic Resonance Angiography | Male | Consensus | Takotsubo Cardiomyopathy - complications | Coronary Angiography | Vascular Diseases - congenital | Coronary Vessel Anomalies - complications | Coronary Vasospasm - complications | Coronary Disease - complications | Coronary Thrombosis - complications | Female | Myocardial Infarction - etiology | Index Medicus | Medicin och hälsovetenskap
Journal Article
European heart journal supplements, ISSN 1520-765X, 02/2019, Volume 21, Issue Supplement_A, pp. A2 - A5
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Sodium, Potassium-Adenosinetriphosphatase | Arrhythmia | Na,K-ATPase | Hyperkalaemia | Potassium homoeostasis | Plasma potassium | Sudden cardiac death | Potassium | Na,K-Pumps | Serum potassium
Journal Article
European heart journal, ISSN 0195-668X, 2016, Volume 37, Issue 3, pp. 267 - +
no | Cangrelor | Angioplasty | Anticoagulation | Bivalirudin | Nitrates | Rhythm monitoring | Dabigatran | Platelet inhibition | Stent | European society of cardiology | Guidelines | Recommendations | Rivaroxaban | Vorapaxar | Apixaban | Fondaparinux | Ticagrelor | Revascularization | Aspirin | Acute cardiac care | Unstable angina | Enoxaparin | Myocardial ischaemia | Beta-blockers | High-sensitivity troponin | Statin | Atherothrombosis | Glycoprotein IIb/IIIa inhibitors | Prasugrel | Early invasive strategy | Clopidogrel | Non-ST-elevation myocardial infarction | Bypass surgery | Chest pain unit | Diabetes | Heparin | Acute coronary syndromes | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Biomarkers - metabolism | Risk Assessment - methods | Diagnosis, Differential | Physical Examination - methods | Humans | Anticoagulants - therapeutic use | Hemorrhage - prevention & control | Long-Term Care | Angina Pectoris - etiology | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Cardiotonic Agents - therapeutic use | Algorithms | Coronary Angiography - methods | Percutaneous Coronary Intervention - methods | Acute Coronary Syndrome - diagnosis | Electrocardiography | Non-ST Elevated Myocardial Infarction - therapy | Acute Coronary Syndrome - therapy | Platelet Aggregation Inhibitors - therapeutic use | Non-ST Elevated Myocardial Infarction - diagnosis | Purinergic P2Y Receptor Antagonists - therapeutic use | Index Medicus | Anticoagulants | Risk Assessment | Angina Pectoris | Platelet Glycoprotein GPIIb-IIIa Complex | Hemorrhage | Cardiotonic Agents | Life Sciences | Coronary Angiography | Human health and pathology | Non-ST Elevated Myocardial Infarction | Platelet Aggregation Inhibitors | Biomarkers | Physical Examination | Purinergic P2Y Receptor Antagonists | Percutaneous Coronary Intervention | Cardiology and cardiovascular system | Acute Coronary Syndrome
Journal Article